Cours Tandem Diabetes Care Inc Nasdaq
Actions
US8753721047
Equipement, fournitures et distribution médicale
CA 2024 * | 869 M 778 M | CA 2025 * | 961 M 861 M | Capitalisation | 2,61 Md 2,34 Md |
---|---|---|---|---|---|
Résultat net 2024 * | -110 M -98,48 M | Résultat net 2025 * | -74 M -66,25 M | VE / CA 2024 * | 2,9 x |
Trésorerie nette 2024 * | 88,94 M 79,63 M | Trésorerie nette 2025 * | 48,12 M 43,09 M | VE / CA 2025 * | 2,67 x |
PER 2024 * |
-24,4
x | PER 2025 * |
-36,3
x | Employés | - |
Rendement 2024 * |
-
| Rendement 2025 * |
-
| Flottant | 99,24% |
Dernier transcript sur Tandem Diabetes Care Inc
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
John Sheridan
CEO | Chief Executive Officer | 68 | 01/03/13 |
Leigh Vosseller
DFI | Director of Finance/CFO | 51 | 01/09/13 |
Shannon Hansen
CMP | Compliance Officer | 58 | 01/01/22 |
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Chairman | 63 | 03/01/19 | |
Director/Board Member | 64 | 01/07/13 | |
John Sheridan
CEO | Chief Executive Officer | 68 | 01/03/13 |
Varia. 1 janv. | Capi. | |
---|---|---|
-5,50% | 181 Md | |
-5,79% | 99,52 Md | |
-6,59% | 65,82 Md | |
-8,38% | 45,21 Md | |
+8,42% | 43,85 Md | |
+10,10% | 42,17 Md | |
+10,97% | 28,75 Md | |
+18,89% | 25,39 Md | |
-8,39% | 23,5 Md |